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Abstract
Sickle Cell Disorder is a global health problem with psychosocial implications. Nigeria has the largest population of
people with sickle cell disorder, with about 150,000 births annually. This study explored the psychosocial impact of
sickle cell disorder in 408 adolescents and adults attending three hospitals in Lagos, Nigeria. A questionnaire was
designed for the study, with some of commonly described areas of psychosocial impact including general public
perceptions and attitudes, education, employment, and healthcare issues, and emotional responses.
The majority of participants thought that society in general had a negative image of SCD, and reported negative
perceptions and attitudes. Some issues in education, employment, and healthcare were expressed, however these
were in the minority of cases. The results also showed that depressive feelings were experienced in almost half the
study population, even though feelings of anxiety or self-hate were uncommon. Clinical implications of these find-
ings are considered.
Introduction and Prevalence
Sickle Cell Disease (SCD) and Thalassaemia are classi-
fied as the two main Haemoglobin Disorders, and in
recent years have been acknowledged to have a global
impact by the World Health Organisation (WHO). SCD
comprises a group of inherited red blood cell conditions
that result from the synthesis of variant or mutant hae-
moglobins. Over 300,000 babies are born worldwide
with SCD mostly in low and middle income countries,
with the majority of these births in Africa [1]. SCD ori-
ginates in tropical regions as a result of its advantage
against malaria. It is predominant among people from
African, Asian, Arabian and Mediterranean countries;
nonetheless it is a global health problem because of
population migration. SCD results in early childhood
death if left untreated, and its effect on the burden of
health care is being recognised as a global issue in terms
of chronic disease. Inheritance of a single sickle haemo-
globin (HbS) gene results in a healthy sickle cell carrier
state, while the inheritance of the HbS gene from both
parents, or HbS with another variant haemoglobin gene
(eg HbC, Hbb-thalassaemia) results in symptomatic
SCD.
Generally, the prevalence of healthy carriers (sickle
cell trait) ranges between 10% and 40% across equatorial
Africa and decreases to between 1% and 2% in Northern
Africa and less than 1% in Southern Africa. In West
African countries such as Ghana and Nigeria, the fre-
quency of carriers is 15% to 30% while in East African
countries such as Uganda and Tanzania it shows wide
variations of up to 45% in some areas [2]. This distribu-
tion is thought to reflect current or historic exposure to
plasmodium malaria infection as carriers appear to be
protected from malaria associated deaths and thus have
improved survival and therefore continued transmission
of the HbS gene. The incidence of SCD at birth is deter-
mined by the prevalence of carriers in the population.
SCD has remarkable public health implications for
Africa. It contributes the equivalent of 5% to under-five
deaths in Africa, with up to 16% in West Africa [1].
Thus in Nigeria, with an estimated carrier prevalence of
24%, 20 per 1000 births are estimated to be affected by
SCD, resulting in 150,000 children with SCD born
annually in Nigeria [2].
Clinical Features and Medical Management
SCD is a chronic condition with recurrent episodes of
pain and symptoms persistent throughout the lives of
individuals. The clinical syndromes include anaemia,
infection, and the consequences of blood vessel blockage
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and is suggested as the cause of the acute painful epi-
sodes, the hallmark of SCD, and other clinical syn-
dromes such as stroke, chest complications, priapism,
leg ulceration and chronic organ failure. The promi-
nence of the pain is the basis upon which SCD has been
named in certain cultures in West Africa [3]. These
indigenous names are characterised by alliteration of let-
ters that apparently signifies the persistence and recur-
rence of its painful symptoms. For example, the term
‘Ahotutuo’ is used by the ‘Twi’ people in Ghana to
describe SCD; and the closest English translations would
include ‘body biting’, ‘body chewing’, and ‘beaten up’ [3].
There is no universal cure for SCD and treatment
options are rather limited, however improved knowledge
has greatly advanced medical management over the past
four decades. Antibiotic prophylaxis is used to prevent
infections especially in children [4]. Other therapies aim
to minimise the effects of symptoms of the disorder.
Painful episodes (crises) are managed primarily with
analgesia, and hydration [5]. Analgesic pain control is
usually in progressive stages and requires a variety of
medications ranging from paracetamol for mild pain to
morphine for severe pain.
Blood transfusions may be required for stroke and
other complications, and hydroxyurea has also been
found to be very effective in reducing the ‘sickling’ pro-
cess and consequently the frequency of pain and hospi-
talisations experienced by patients [5]. Bone marrow
transplantation is a possible cure, however among other
criteria, this requires a matched donor, and unfortu-
nately is not feasible for all affected children [6].
Psychosocial Impact
Psychosocial issues for people with SCD and their
families mainly result from the impact of pain and
symptoms on their daily lives, and society’sa t t i t u d e st o
SCD and those affected. In Africa, cultural factors are
particularly relevant to these problems because of beliefs
and traditional practices. In Nigeria, beliefs are usually
influenced by cultural and religious values, which influ-
ence health behaviour such as coping strategies. For
example, among the Igbo communities, SCD is believed
to be the result of malevolent ‘Ogbanje’ (reincarnation)
that is repeated cycles of birth, death and reincarnation
[7]. Other studies have shown that religious beliefs play
a positive part in coping including prayer, faith in God
and doctors, and a hopeful approach to health difficul-
ties in Nigeria [8,9]. Previous research also revealed that
compared with people with SCD living in the UK, those
i nN i g e r i ac o m m o n l yu s e dp r a y i n ga n dh o p i n ga sa n
affective coping strategy, which seems to be influenced
by external factors such as religion, faith in God, super-
stitions, and stigma [10].
T h eo b j e c to ft h i ss t u d yw a st oe x p l o r et h ep s y c h o s o -
cial impact of SCD within a Nigerian population. It is
acknowledged that psychosocial interventions for people
with SCD are as important as medical treatment for
comprehensive management.
Methods
Pre-study focus groups were conducted earlier to
explore and identify issues in general and specific con-
cerns of individuals with SCD in order to develop or
obtain appropriate measures to be used in the studies.
These groups comprised of adolescents and adults aged
thirteen years and over, were non-directive, but semi-
structured with open-ended questions, and facilitation
towards a goal at the end of each session. There were
two group sessions with 6 to 8 participants, and each
group talked about the same issues with the same set of
questions. A number of open-ended questions were dis-
cussed in each group session, and answers were written
down. The main areas explored included knowledge and
understanding, beliefs, pain experience, coping, health
service utilisation, social issues including education and
employment, and quality of life. This led to the develop-
ment of the questionnaire, which was subsequently used
in the study. However, the questionnaire was not uti-
lised in the focus group sessions.
Measures
Psychosocial Impact of Sickle Cell Disorder - a self-com-
plete questionnaire designed for the study (see Addi-
tional file 1). This is a 28-item questionnaire to
examine: demographics, general perceptions, societal
awareness, teachers and employers’ attitudes, experi-
ences with health services, emotional responses. The
aim was to allow easy categorisation of responses, there-
fore ‘Yes’ and ‘No’ responses were used instead of
‘Likert’ scales for graded responses. This approach was
adopted because of uncertainty about the literacy levels
of some patients. Although there was no validation of
the questionnaire, it was administered to a pilot sample
of patients with SCD attending the National Sickle Cell
Centre in Lagos, with no difficulties in completion
expressed.
Participants
Patients with SCD attending sickle cell outpatients’
clinics in Lagos located at Lagos University Teaching
Hospital, Gbagada General Hospital, Massey Street Chil-
dren Hospital, and the National Sickle Cell Centre were
recruited opportunistically to the study. They were all
administered questionnaires during the clinic appoint-
ment by a team of two psychology interns and a
research assistant over a two-month period. The average
clinic attendance ranged from 30 to 45 at the three
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involved in the recruitment of patients to avoid coer-
cion. The psychology interns and research assistant
introduced the study in the waiting area with an oppor-
tunity for the participants to refuse consent, informing
them that this would not affect their medical treatment.
Results
Demographic characteristics of the participants are pre-
sented in Table 1. The total study sample was 408,
which consisted of 194 males and 214 females. There
were 155 (38%) adolescents aged 14 to18 years, and 253
(62%) adults aged 19 to 56 years.
All the adolescents were students who attended the
Sickle Cell Clinic at Massey Street Children Hospital.
The majority of all participants (75%) were from a Yor-
uba ethnic origin. The attitudes and perception about
SCD were examined under three broad categories of
general public, education and employment, and health
services (Table 2). These were grouped into separate
responses according to Adolescent and Adult ages.
The responses of the adolescents were mostly similar
to the adults. The majority of participants thought that
society in general had a negative image of SCD through
its attitudes and perceptions, although they did not feel
that people had a negative approach towards them
because of their SCD. Nonetheless, a very large propor-
tion of respondents thought that SCD as an illness is
less known in society and needs more awareness, and if
society was more aware of people with SCD it would be
more positive about those with the condition. Partici-
pants had not experienced much teasing and bullying
during their education in school, college or university.
Discrimination from employers was also not widely
reported. Experiences of health services were mostly
positive especially among adolescents, as the vast major-
ity of them felt that medical staff had a good under-
standing of SCD compared to adults. Despite their age
group, most participants acknowledged that medical
staff offered them fair treatment.
Emotional responses to SCD are presented in Table 3.
Nearly half the number of participants indicated feelings
of depression, however feelings of anxiety and self-hate
were much less.
Discussion
The impact of chronic illness such as SCD on indivi-
duals may be grouped into a set of illness-related tasks:
adjusting to the symptoms and incapacities; maintaining
adequate relationships with health-care providers; and
managing the emotional and social consequences of the
illness [11]. The extent to which individuals are affected
by a chronic illness may therefore be determined by
their coping responses since dealing with its continuous
demands requires the acquisition of new skills and mod-
ifications to daily life. Previous studies on psychosocial
aspects of SCD generally examined the extent of its
impact on children and adults, the ways in which
affected families’ function, and the resultant psychologi-
cal adjustment. Some studies demonstrated that SCD is
a risk factor for maladjustment (psychosocial function-
ing) in children and adolescents [12-15]. Earlier research
also showed that rates of poor psychological adjustment
of children with SCD remained relatively constant over
time, however there was less stability in child psycholo-
gical adjustment reported by children as opposed to
reports by mothers [16].
This study sought to explore the psychosocial impact
of SCD in a Nigerian population. The results support
the notion that society’s attitudes and perceptions had a
psychosocial impact on people with SCD. Health beliefs
could be influenced by external factors such as advice
given by health workers, family support, and work
responsibility. Beliefs can also be influenced by their cul-
ture. For example, it has been suggested that Nigerians
have tried religious healing (prayer) as an alternative
approach or in addition to routine medical treatment
Table 1 Demographic Characteristics of Patients
Attending Sickle Cell Clinics in Lagos
Variable Frequency
Age Groups:
14-18 155 (38%)
19-23 108 (27%)
24-28 93 (23%)
29-33 28 (7%)
34-38 12 (3%)
39-43 6 (1%)
44-56 6 (1%)
Gender:
Male 194 (48%)
Female 214 (52%)
Ethnic Origin:
Hausa/Fulani 4 (1%)
Igbo 52 (13%)
Yoruba 305 (75%)
Others 47 (11%)
Occupation:
Employed 60 (15%)
Student 311 (76%)
Housework 7 (2%)
Seeking Employment 25 (6%)
Retired 1 (0%)
Other 4 (1%)
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ted to “divine retribution” or the supernatural. There
are cultural variations in concepts of health and illness
relating to: views of illness, causes of ill health; accepta-
ble treatment, types of treatment believed to be effective;
reaction to symptoms, use of appropriate services.
Within the Nigerian context, such beliefs lead to nega-
tive perceptions and attitudes about SCD.
About three-quarters of the study population were
students, and over a third were adolescents aged 14 to
18 years. Anecdotal evidence suggests teasing and bully-
ing are common complaints among school going chil-
dren with SCD. This was reported in 23% of the study
population. Other major psychosocial problems experi-
enced by young people with SCD during their school
going years have also been described in focus groups
[18]. Important issues include fear of early death, fear of
talking to friends and teachers about the condition,
embarrassment about bedwetting and reluctance to take
part in school trips because of this, teasing by colleagues
d u et oj a u n d i c ea n da s s o c i a t ed discolouration of their
eyes, and anger should ill-informed staff consider the
child as lazy and wanting to keep away from school
activities. Anxieties that young people with SCD
experience at school may result in the development of a
negative image of themselves, teachers and school staff.
Mood is an important consequence of SCD. People
with SCD commonly report low self-esteem and feelings
of hopelessness as a result of frequent pain, hospitalisa-
tions, and loss of schooling (in children) and employ-
ment (in adults). These accounts could indicate
depressive symptoms. Some studies have revealed anxi-
ety and depression in children with SCD [19], and
depression in adults [20]. Consistent with the literature,
a considerable number the patients in this study had
feelings of depression. Feelings of anxiety and self-hate
were uncommon. Ohaeri and colleagues [8] in their
work with 170 patients aged 11-20 years, in Nigeria,
a l s on o t e dt h a ta b o u t8 8 %w e r ew o r r i e da n d5 5 %h a s
depressive thoughts about their condition.
There is considerable variability in the ability of peo-
ple with SCD to cope with their condition. People with
SCD experience different levels of health, and such var-
iations can lead to differences in psychosocial function-
ing. Some people cope relatively well, attend school or
work, and are active physically and socially. Others cope
inadequately’ leading more limited and secluded lives.
Nonetheless, this may not necessarily be a consequence
of severity of their condition, and the reasons for these
should be sought and addressed. Quality of life in peo-
ple with SCD may therefore be more impaired than that
of the general population.
There are some limitations to the study. The use of
dichotomous questions was mainly to address possible
literacy problems in some patients who may have found
it difficult to grade their responses on a Likert type
scale, thus avoiding confusion. Dichotomous questions
are useful in situations where the intention is to direct
Table 2 Responses to Attitudes and Perceptions about Sickle Cell Disorder
Yes No
Category Adolescents
N = 155
Adults
N = 253
Adolescents
N = 155
Adults
N = 253
General Public:
Negative Societal Attitudes/Perception 96 (62%) 168 (66%) 59 (38%) 85 (34%)
Negative Approach by People 41 (27%) 93 (37%) 114 (73%) 160 (63%)
Need for More Awareness 132 (85%) 207 (82%) 23 (15%) 69 (18%)
Positive Effect of More Awareness 123 (79%) 198 (78%) 32 (21%) 55 (22%)
Education and Employment:
Teasing/Bullying 29 (19%) 66 (26%) 126 (81%) 187 (74%)
Teacher/Staff Support 94 (61%) 128 (51%) 61 (39%) 125 (49%)
Employers Knowledge of SCD Status 0 (0%) 164 (40%) 0 (0%) 244 (60%)
Employers Discrimination 0 (0%) 77 (19%) 0 (0%) 331 (81%)
Health Services:
Negative Attitudes 42 (27%) 79 (31%) 113 (73%) 174 (69%)
Good Understanding 144 (93%) 144 (57%) 11 (7%) 109 (43%)
Fair Treatment 103 (66%) 160 (63%) 52 (34%) 93 (37%)
Table 3 Emotional Responses to Sickle Cell Disorder
Emotion Frequency
Adolescents
N = 155
Adults
N = 253
Self-Hate 9 (6%) 21 (8%)
Depressive Feelings 84 (54%) 112 (44%)
Anxiety Feelings 11 (7%) 33 (13%)
All Emotions 7 (5%) 25 (10%)
None 44 (28%) 62 (25%)
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perspectives. However, a major drawback is that ques-
tions have only fixed alternatives, that is ‘Yes’ and ‘No’
in this case. Closed questions do not allow respondents
to qualify or explain their answers, which may lead to
bias in the interpretation due to the categories imposed.
No standard questionnaires for the psychosocial impact
of sickle cell disorder were identified from previous
research, nor were there generic psychosocial impact
measures in the chronic illness literature that could be
employed for the purpose of this study.
Furthermore, information obtained was cross-sec-
tional, longitudinal data would have enhanced the
results. More information on socio-economic status
would have been useful. Also, the opportunistic selec-
tion of patients in a clinic setting may have been biased;
a community-based study may have yielded different
results, given that the views of patients not receiving
medical treatment could be di f f e r e n t .N o n e t h e l e s s ,t h e
study contributes to our understanding of the psychoso-
cial impact of SCD within the African setting.
T h ef i n d i n g so ft h i se x p l o r a t o r ys t u d yi n d i c a t et h a t
there is a need to develop appropriate psychosocial
interventions within a global context. The aim should
be more public education about SCD to change beliefs,
attitudes, and stigma as a starting point. This should be
followed by other interventions that are tailored depend-
ing on access to health care at different levels, and in
different settings. In developing countries such as
Nigeria, the focus would be initiating basic psychosocial
interventions by non-specialised health workers in a pri-
mary care team at a Community Health Post (Level 1)
or Primary Health Centre (Level 2), where psychologists
or social workers are not be available. This would be in
line with the WHO’s current priority of primary care as
a hub of coordination for person-centred care [21].
Within the global context, the aims of psychosocial
interventions in chronic illnesses such as SCD are to
help reduce negative thoughts and feelings about the
condition, and encourage the acquisition or mainte-
nance of coping strategies. In the case of SCD, psycholo-
gical therapies should be offered as standard care in the
management of SCD adjunctive to routine medical
treatment, where studies of these therapies have shown
encouraging results [22]. The overall goal is to help
patients cope better, fulfil roles, and to achieve better
quality of life. These interventions should be age-appro-
priate, and available in both hospital clinics and commu-
nity-based settings depending on access.
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